TCM
XLRN

Teza Capital Management’s Acceleron Pharma XLRN Stock Holding History

Teza Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,617
Closed -$450K – 563
2021
Q3 		$450K Buy
+2,617
New +$342K 0.22% 144

Teza Capital Management's XLRN Position: Q4 2021 in Review

Teza Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,617 shares — an estimated $450K sold.

Teza Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $450K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Teza Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Teza Capital Management sold 2,617 Acceleron Pharma shares in Q4 2021, an estimated $450K.
  • Teza Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Teza Capital Management's Acceleron Pharma position peaked at $450K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Teza Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.